Van Eck Associates Corp Exact Sciences Corp Transaction History

Van Eck Associates Corp

  • $80.1 Billion
  • Q3 2024

A detailed history of Van Eck Associates Corp transactions in Exact Sciences Corp stock. As of the latest transaction made, Van Eck Associates Corp holds 135,865 shares of EXAS stock, worth $9.46 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
135,865
Previous 153,349 11.4%
Holding current value
$9.46 Million
Previous $6.48 Million 47.37%
% of portfolio
0.01%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024
SELL
$42.43 - $70.83 $741,846 - $1.24 Million
-17,484 Reduced 11.4%
135,865 $9.55 Million
Q2 2024

Jul 31, 2024
BUY
$41.33 - $74.26 $321,754 - $578,114
7,785 Added 5.35%
153,349 $6.48 Million
Q1 2024

Apr 30, 2024
BUY
$56.27 - $73.77 $291,140 - $381,685
5,174 Added 3.69%
145,564 $10.1 Million
Q4 2023

Feb 05, 2024
SELL
$59.06 - $75.72 $536,146 - $687,386
-9,078 Reduced 6.07%
140,390 $10.4 Million
Q3 2023

Nov 08, 2023
SELL
$65.94 - $99.04 $1.08 Million - $1.62 Million
-16,345 Reduced 9.86%
149,468 $10.2 Million
Q2 2023

Aug 03, 2023
SELL
$62.68 - $95.05 $123,416 - $187,153
-1,969 Reduced 1.17%
165,813 $15.6 Million
Q1 2023

May 03, 2023
SELL
$47.19 - $70.77 $1.42 Million - $2.13 Million
-30,116 Reduced 15.22%
167,782 $11.4 Million
Q4 2022

Feb 08, 2023
BUY
$30.35 - $53.15 $2.08 Million - $3.64 Million
68,538 Added 52.98%
197,898 $9.8 Million
Q3 2022

Oct 27, 2022
SELL
$31.97 - $49.37 $1.52 Million - $2.34 Million
-47,410 Reduced 26.82%
129,360 $4.2 Million
Q2 2022

Aug 03, 2022
SELL
$35.61 - $76.23 $200,769 - $429,784
-5,638 Reduced 3.09%
176,770 $6.96 Million
Q1 2022

May 10, 2022
BUY
$57.56 - $82.54 $6,676 - $9,574
116 Added 0.06%
182,408 $12.8 Million
Q4 2021

Jan 26, 2022
SELL
$72.5 - $100.68 $964,322 - $1.34 Million
-13,301 Reduced 6.8%
182,292 $14.2 Million
Q3 2021

Nov 03, 2021
SELL
$90.24 - $124.05 $1.44 Million - $1.97 Million
-15,920 Reduced 7.53%
195,593 $18.7 Million
Q2 2021

Aug 10, 2021
BUY
$93.66 - $139.27 $3.97 Million - $5.91 Million
42,417 Added 25.08%
211,513 $26.3 Million
Q1 2021

May 13, 2021
BUY
$116.57 - $155.01 $627,030 - $833,798
5,379 Added 3.29%
169,096 $22.3 Million
Q4 2020

Feb 09, 2021
SELL
$99.61 - $142.12 $2.1 Million - $3 Million
-21,095 Reduced 11.41%
163,717 $21.7 Million
Q3 2020

Nov 12, 2020
SELL
$72.92 - $102.01 $2.27 Million - $3.17 Million
-31,108 Reduced 14.41%
184,812 $18.8 Million
Q2 2020

Aug 10, 2020
BUY
$55.75 - $92.75 $1.71 Million - $2.85 Million
30,677 Added 16.56%
215,920 $18.8 Million
Q1 2020

May 12, 2020
SELL
$37.9 - $104.44 $159,710 - $440,110
-4,214 Reduced 2.22%
185,243 $10.7 Million
Q4 2019

Feb 13, 2020
BUY
$77.66 - $99.74 $4.09 Million - $5.25 Million
52,679 Added 38.51%
189,457 $17.5 Million
Q3 2019

Nov 08, 2019
SELL
$90.37 - $122.49 $356,961 - $483,835
-3,950 Reduced 2.81%
136,778 $12.4 Million
Q2 2019

Aug 07, 2019
SELL
$89.51 - $118.04 $6.47 Million - $8.54 Million
-72,333 Reduced 33.95%
140,728 $16.6 Million
Q1 2019

May 13, 2019
SELL
$61.98 - $96.5 $2.37 Million - $3.69 Million
-38,286 Reduced 15.23%
213,061 $18.5 Million
Q4 2018

Feb 12, 2019
SELL
$56.04 - $82.66 $417,722 - $616,147
-7,454 Reduced 2.88%
251,347 $15.9 Million
Q3 2018

Nov 13, 2018
BUY
$48.29 - $80.6 $12.5 Million - $20.9 Million
258,801 New
258,801 $20.4 Million

Others Institutions Holding EXAS

# of Institutions
636
Shares Held
166M
Call Options Held
1.93M
Put Options Held
1.23M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email